Zhitong Finance App News, Jingtai Holdings (02228.HK) announced that QuantumPharm Limited and Jingtai Intelligent Pharmaceutical Technology (Shanghai) Co., Ltd. (both wholly-owned subsidiaries of the Company) and Pierre Fabre Médicament SAS (Laboratoires Pierre Fabre Group member company, “Laboratoires Pierre Fabre”) have signed a research cooperation agreement (cooperation). The Group and Laboratoires Pierre Fabre will collaborate on the discovery of novel clinical drug candidates in various research projects in the field of oncology, possibly covering the fields of dermatology and rare diseases.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.